Top broker says these ASX 200 stocks are buys following the market selloff

Let's see what the broker is recommending following recent weakness.

Now could be an opportune time to load up on some quality ASX 200 stocks according to one top broker.

According to a note out of Wilsons, its analysts believe that the recent market selloff has created an attractive risk/reward for Australian investors.

So, if you can stomach some volatility, then the stocks in this article could be worth considering. It said:

Following the pullback, the risk/reward of the ASX 200 has become increasingly attractive, with valuations now broadly in line with the historical average. However, we expect volatility to remain elevated over the near-term, with the prospect of tariffs remaining a market overhang until at least 2 April, when the US Department of Commerce is scheduled to release its comprehensive trade review.

Wilsons has highlighted a number of stocks to buy that feature in its Focus Portfolio. Let's see what they are:

Business man marking buy on board and underlining it.

Image Source: Getty Images

Goodman Group (ASX: GMG)

This integrated industrial property giant could be an ASX 200 stock to buy according to the broker.

It highlights that its shares have pulled back meaningfully following a capital raising and the market selloff. Given its positive earnings outlook, it feels this has presented an opportunity for investors. It said:

GMG has pulled back largely due to last month's ~$4.4n capital raise to fund its data centre strategy. Notwithstanding the near-term equity dilution from the raise, GMG's EPS growth outlook remains attractive, underpinned by its data centre pipeline which will benefit from strong sector tailwinds from cloud migration and AI. We expect GMG to fund future developments with recycled capital (existing liquidity, retained earnings, equity sell-downs) and a modest amount of leverage

ResMed Inc. (ASX: RMD)

Another ASX 200 stock to get the thumbs up from Wilsons is sleep disorder treatment company ResMed.

It highlights that its shares have pulled back despite its strong second quarter update. The broker explains:

RMD has pulled back despite its strong Q2 EPS beat which drove consensus EPS upgrades. In the result management pointed to strong fundamentals as it highlighted 'once in a generation' tailwinds supporting CPAP demand over the medium-term (wearables, GLPs). At a PE of ~22x, RMD trades on a ~30% discount to its five-year average, which represents attractive value considering double-digit consensus EPS growth over the medium-term.

WiseTech Global Ltd (ASX: WTC)

Finally, this logistics solutions technology company could be cheap by historical standards according to the broker.

Commenting on the ASX 200 stock's significant decline, Wilsons said:

At a PE of ~60x, WTC trades at its lowest PE multiple in ~two years, offering highly attractive value on a growth-adjusted basis (3yr PEG of ~1.7x). WTC has pulled back following slight delays to the launch of Container Transport Optimisation (CTO). Despite the near-term downgrades, the medium/long-term earnings growth trajectory is broadly unchanged and remains attractive. WTC's 3 year EPS CAGR of >30% will be underpinned by 1) new customer wins, 2) large freight forwarder rollouts, and 3) the rollout of CTO (set to be launched initially in Australia in 2H25).

Motley Fool contributor James Mickleboro has positions in Goodman Group, ResMed, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group, ResMed, and WiseTech Global. The Motley Fool Australia has positions in and has recommended ResMed and WiseTech Global. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two male ASX investors and executives wearing dark coloured suits sit at a table holding their mobile phones discussing the highest trading ASX 200 shares today
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, CBA shares

We review three fresh buy, hold, and sell calls from John Athanasiou at Red Leaf Securities.

Read more »

colleagues on a lunch break looking at iPhone
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

7 ASX 200 shares in the buy zone as optimism returns to the market: experts

Brokers reaffirmed their buy calls on Liontown, Rio Tinto, Xero, and others this week.

Read more »